NCT06023290Completed
Validation of Digital Heart Rhythm Devices in the Detection of Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 1 Dec 2023
Brief summary (registry, in English)
The VALIDATION study aims to evaluate the performance of four state-of-the-art digital heart rhythm devices (Preventicus®, FibriCheck®, Apple Watch®, 6L Kardia Mobile®) for the detection of atrial fibrillation.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 126 (actual)
- First submitted
- 4 Jul 2023
- Start date
- 3 Jul 2023
- Primary completion date
- 27 Oct 2023
- Lead sponsor
- Ziekenhuis Oost-Limburg
- Diseases
- Atrial fibrillation
- NCT number
- NCT06023290
What you commit to
- Study type: Interventional
- Participants enrolled: 126
- From 3 Jul 2023 to the primary completion date, 27 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients with a pacemaker
- Inclusion in another clinical trial that may influence the results of this trial
- The patient is unable to comprehend the informed consent.
Who the study is looking for
- The patient is an ambulatory cardiology patient.
- The patient is at least 18 years old.
- The patient is sinus or in atrial fibrillation.
- The patient is able to perform the study procedures together with the study assistant.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ziekenhuis Oost-Limburg Coordinator of this site? Confirm its status | Genk | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.